BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7803762)

  • 1. The mitogen-activated protein kinases, ERK1 and ERK2.
    Cobb MH; Hepler JE; Cheng M; Robbins D
    Semin Cancer Biol; 1994 Aug; 5(4):261-8. PubMed ID: 7803762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins.
    Gopalbhai K; Meloche S
    J Cell Physiol; 1998 Jan; 174(1):35-47. PubMed ID: 9397154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
    Greulich H; Reichman C; Hanafusa H
    Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of MAP kinase (ERK1/ERK2) activity by phosphorylated glia maturation factor (GMF).
    Zaheer A; Lim R
    Biochemistry; 1996 May; 35(20):6283-8. PubMed ID: 8639570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.
    Zanella CL; Posada J; Tritton TR; Mossman BT
    Cancer Res; 1996 Dec; 56(23):5334-8. PubMed ID: 8968079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma.
    McKillop IH; Schmidt CM; Cahill PA; Sitzmann JV
    Hepatology; 1997 Dec; 26(6):1484-91. PubMed ID: 9397988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1.
    Ward Y; Gupta S; Jensen P; Wartmann M; Davis RJ; Kelly K
    Nature; 1994 Feb; 367(6464):651-4. PubMed ID: 8107850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical endothelial damage results in basic fibroblast growth factor-mediated activation of extracellular signal-regulated kinases.
    Pintucci G; Steinberg BM; Seghezzi G; Yun J; Apazidis A; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
    Surgery; 1999 Aug; 126(2):422-7. PubMed ID: 10455916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network.
    Robbins DJ; Zhen E; Cheng M; Xu S; Ebert D; Cobb MH
    Adv Cancer Res; 1994; 63():93-116. PubMed ID: 8036991
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation and properties of extracellular signal-regulated protein kinases 1, 2, and 3.
    Robbins DJ; Zhen E; Cheng M; Xu S; Vanderbilt CA; Ebert D; Garcia C; Dang A; Cobb MH
    J Am Soc Nephrol; 1993 Nov; 4(5):1104-10. PubMed ID: 8305637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases.
    Saba-el-Leil MK; Malo D; Meloche S
    Mamm Genome; 1997 Feb; 8(2):141-2. PubMed ID: 9060415
    [No Abstract]   [Full Text] [Related]  

  • 12. Human mitogen-activated protein kinase CSBP1, but not CSBP2, complements a hog1 deletion in yeast.
    Kumar S; McLaughlin MM; McDonnell PC; Lee JC; Livi GP; Young PR
    J Biol Chem; 1995 Dec; 270(49):29043-6. PubMed ID: 7493921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossreactivity of anti-dual phosphorylated antibodies with actin.
    Martín-Blanco E; Martinez-Arias A; Jarvis B
    Trends Cell Biol; 1998 Oct; 8(10):419. PubMed ID: 9789332
    [No Abstract]   [Full Text] [Related]  

  • 14. Diversity in function and regulation of MAP kinase pathways.
    Blumer KJ; Johnson GL
    Trends Biochem Sci; 1994 Jun; 19(6):236-40. PubMed ID: 8073500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAP kinases in meiosis.
    Murray AW
    Cell; 1998 Jan; 92(2):157-9. PubMed ID: 9458040
    [No Abstract]   [Full Text] [Related]  

  • 16. A dual role for ERK-1/2 in the regulation of plasmin activity and cell migration in metastatic NSCLC-H1299 cells.
    Zeitlmayr S; Cami D; Selmani B; Gudermann T; Breit A
    Arch Toxicol; 2023 Dec; 97(12):3113-3128. PubMed ID: 37712947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DisCanVis: Visualizing integrated structural and functional annotations to better understand the effect of cancer mutations located within disordered proteins.
    Deutsch N; Pajkos M; Erdős G; Dosztányi Z
    Protein Sci; 2023 Jan; 32(1):e4522. PubMed ID: 36452990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of extracellular-signal regulated kinase 1/2 activity to the memory trace.
    Ojea Ramos S; Feld M; Fustiñana MS
    Front Mol Neurosci; 2022; 15():988790. PubMed ID: 36277495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway.
    Zhang B; Li F; Zhu Z; Ding A; Luo J
    Cancer Manag Res; 2020; 12():8951-8964. PubMed ID: 33061591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the substrate proteins of U-box E3s E4B and CHIP by orthogonal ubiquitin transfer.
    Bhuripanyo K; Wang Y; Liu X; Zhou L; Liu R; Duong D; Zhao B; Bi Y; Zhou H; Chen G; Seyfried NT; Chazin WJ; Kiyokawa H; Yin J
    Sci Adv; 2018 Jan; 4(1):e1701393. PubMed ID: 29326975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.